Home> Products> necessary information

{ "products": [ { "_id": "67122b0ce42a258b4935925e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pantoprazole (40 mg)", "description": "PANTOSTRUM IV INJECTION is a potent medication designed to manage acid-related disorders. This injectable formulation is particularly useful for patients who require immediate therapeutic intervention, such as those unable to take oral medications. Containing Pantoprazole (40 mg), a powerful proton pump inhibitor (PPI), PANTOSTRUM IV effectively reduces gastric acid secretion, providing relief from conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.\n\nThis product is administered intravenously, ensuring rapid onset of action, which is crucial in managing acute situations where oral administration may not be feasible.\n\n \nKey Benefits: \n \n\nRapid Relief: The intravenous formulation provides quick relief from acid-related symptoms, making it suitable for acute conditions.\n\nEffective for a Range of Conditions: PANTOSTRUM IV is beneficial for treating gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.\n\nPrevents Recurrent Symptoms: Regular use can help prevent the recurrence of acid-related symptoms, improving the quality of life for patients with chronic conditions.\n\nSafe for Short-Term Use: While PPIs are typically used for longer durations, this injectable form is safe for short-term management in a hospital or clinical setting.\n\nWell-Tolerated: Most patients tolerate Pantoprazole well, with a favorable safety profile compared to other PPIs.\n\n \nHow Does It Work?\n \n\nPANTOSTRUM IV INJECTION contains Pantoprazole, which selectively inhibits the H+/K+ ATPase enzyme (the proton pump) located in the gastric parietal cells. By blocking this enzyme, Pantoprazole effectively reduces the secretion of gastric acid into the stomach. The decreased acid production alleviates symptoms associated with acid reflux and protects the gastric mucosa from damage due to excessive acid.\n\nThe rapid onset of action provided by the intravenous route makes it especially useful for patients experiencing severe symptoms or those in critical care situations, where immediate acid suppression is necessary.\n\n \nDirections for Use:\n \n\nAdministration: PANTOSTRUM IV INJECTION should be administered by a healthcare professional.\nDosage: The typical adult dosage is 40 mg, administered once daily. For certain conditions, higher dosages or more frequent administration may be necessary, as determined by a physician.\nInfusion Method: The injection should be diluted appropriately and infused slowly over 2-15 minutes, as recommended in the prescribing information.\nNote: Always follow the healthcare provider’s instructions regarding dosage and duration of therapy.\n\n \nSide Effects:\n \n\nWhile PANTOSTRUM IV INJECTION is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nHeadache: A frequent side effect, which may resolve on its own.\nDiarrhea: Some patients may experience gastrointestinal disturbances.\nNausea/Vomiting: Mild nausea or vomiting may occur in some individuals.\nDizziness: A sensation of light-headedness can occur but is usually transient.\nInjection Site Reactions: Pain or irritation at the injection site may happen but is generally mild.\nSerious Side Effects: Although rare, serious side effects may include severe allergic reactions, liver dysfunction, or kidney problems. Seek immediate medical attention if any severe symptoms occur.", "price": 56.5, "discountamount": 16.95, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "other PPIs", "Regular use", "Mild nausea", "rapid onset", "acid reflux", "quick relief", "Rapid Relief", "2-15 minutes", "Key Benefits", "Most patients", "peptic ulcers", "Short-Term Use", "higher dosages", "excessive acid", "gastric mucosa", "kidney problems", "Infusion Method", "severe symptoms", "acid production", "acute conditions", "clinical setting", "longer durations", "oral medications", "acute situations", "liver dysfunction", "intravenous route", "potent medication", "chronic conditions", "Recurrent Symptoms", "oral administration", "healthcare provider", "H+/K+ ATPase enzyme", "Common side effects", "typical adult dosage", "frequent side effect", "acid-related symptoms", "short-term management", "injectable formulation", "acid-related disorders", "gastric acid secretion", "gastric parietal cells", "prescribing information", "healthcare professional", "intravenous formulation", "frequent administration", "PANTOSTRUM IV INJECTION", "Injection Site Reactions", "critical care situations", "favorable safety profile", "severe allergic reactions", "Zollinger-Ellison syndrome", "immediate acid suppression", "rare, serious side effects", "immediate medical attention", "gastrointestinal disturbances", "powerful proton pump inhibitor", "gastroesophageal reflux disease", "immediate therapeutic intervention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1993, "imageuri": "https://productimages.withfloats.com/actual/67122b10ce3b6899c42f8e60.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122b10ce3b6899c42f8e60.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:31:56.085Z", "updatedon": "2024-10-18T09:31:56.085Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pantoprazole-40-mg-/1993", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM IV INJECTION ", "category": "GASTROLOGYRANGE", "tags": [ "pantop injection i.v. or im", "Pantoprazole injection uses", "Pantoprazole IV infusion guidelines", "Pantoprazole injection 40 mg uses", "Pan 40 Injection im or IV", "Pantoprazole injection uses", "Pantop इंजेक्शन in Hindi", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d8411681222f3e95891586", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Collagen Peptides, Magnesium , N - Acetylglucosamine, Amino Acids & Vitamins Powder", "description": "COLLABOOST MG SACHET \nCollagen Peptides, Magnesium , N - Acetylglucosamine, Amino Acids & Vitamins Powder\nCollaboost MG Sachet is a meticulously formulated supplement designed to support joint health, enhance skin elasticity, and improve overall well-being. This potent blend of collagen peptides, magnesium, N-acetylglucosamine, amino acids, and essential vitamins works synergistically to provide comprehensive support for the body's structural and functional integrity. Ideal for individuals seeking to maintain an active lifestyle and those aiming to improve their skin health, Collaboost MG Sachet offers a convenient and effective solution.\n\n \n\nKey Benefits:\n \n\nSupports Joint Health: The combination of collagen peptides and N-acetylglucosamine promotes joint lubrication and cartilage regeneration, helping to maintain joint flexibility and reduce discomfort.\nEnhances Skin Elasticity: Collagen peptides help to improve skin hydration and elasticity, reducing the appearance of fine lines and wrinkles.\nPromotes Muscle Recovery: Amino acids facilitate muscle repair and growth, making this supplement ideal for individuals with active lifestyles.\nImproves Bone Health: Magnesium and collagen work together to support bone density and strength, reducing the risk of fractures.\nBoosts Overall Well-being: The blend of vitamins and minerals in Collaboost MG Sachet supports various bodily functions, enhancing energy levels and overall health.\n \nHow Does It Work?\n \n\nCollaboost MG Sachet works through the synergistic action of its key ingredients. Collagen peptides provide the necessary building blocks for maintaining the structural integrity of skin, joints, and bones. Magnesium supports muscle relaxation and bone health, while N-acetylglucosamine enhances joint lubrication and mobility. Amino acids aid in muscle repair and growth, and the included vitamins provide essential nutrients that support various bodily functions. Together, these components ensure comprehensive support for the body's structural and functional needs.\n\n \nDirections for Use:\n \n\nDosage: Empty the contents of one sachet into a glass of water or your favorite beverage. Stir well until fully dissolved.\nTiming: For optimal results, consume one sachet daily, preferably with a meal.\nStorage: Store in a cool, dry place away from direct sunlight.\n \nSide Effects:\n \n\nCollaboost MG Sachet is generally well-tolerated. However, some individuals may experience mild side effects such as:\n\nDigestive Upset: Including symptoms like bloating, gas, or mild diarrhea, especially when first starting the supplement.\nAllergic Reactions: Rarely, individuals may experience allergic reactions to any of the ingredients. Symptoms might include rash, itching, or swelling.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 110.0, "discountamount": 33.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "fine lines", "one sachet", "skin health", "Bone Health", "Amino Acids", "potent blend", "bone density", "Key Benefits", "joint health", "energy levels", "muscle repair", "mild diarrhea", "skin hydration", "overall health", "skin elasticity", "key ingredients", "Vitamins Powder", "Digestive Upset", "direct sunlight", "optimal results", "Muscle Recovery", "cool, dry place", "functional needs", "active lifestyle", "Collagen Peptides", "favorite beverage", "muscle relaxation", "joint flexibility", "joint lubrication", "mild side effects", "essential vitamins", "Allergic Reactions", "synergistic action", "effective solution", "overall well-being", "essential nutrients", "structural integrity", "functional integrity", "COLLABOOST MG SACHET", "comprehensive support", "cartilage regeneration", "various bodily functions", "necessary building blocks" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1963, "imageuri": "https://productimages.withfloats.com/actual/66d841362313473aa80ee0d4.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/66d841362313473aa80ee0d4.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-04T11:14:30.628Z", "updatedon": "2024-09-04T11:14:30.628Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/collagen-peptides-magnesium-n-acetylglucosamine-amino-acids-vitamins-powder/1963", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "COLLABOOST MG SACHET ", "category": "ORTHOPEDICSRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6d7de5556df81ef93a4c9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Atrovastatin Calcium (20mg), Ezetimibe IP (10mg)", "description": "ATOVASTRIN EZ 20/10 \nAtrovastatin Calcium (20mg), Ezetimibe IP (10mg)\nManaging cholesterol levels is crucial for maintaining heart health and reducing the risk of cardiovascular diseases. ATOVASTRIN EZ 20/10 is a powerful combination medication designed to help individuals effectively manage their cholesterol levels. By combining two potent cholesterol-lowering agents, Atorvastatin Calcium and Ezetimibe, this medication offers a comprehensive approach to reducing harmful cholesterol in the body.\n\n \n\nKey Benefits:\n \n\nComprehensive Cholesterol Control: ATOVASTRIN EZ 20/10 effectively lowers LDL cholesterol and triglycerides, while also modestly increasing HDL cholesterol, providing a balanced approach to managing cholesterol levels.\nDual Mechanism of Action: The combination of Atorvastatin and Ezetimibe targets cholesterol production in the liver and absorption in the intestines, offering a more thorough reduction in cholesterol levels.\nCardiovascular Protection: By lowering cholesterol levels, ATOVASTRIN EZ 20/10 helps reduce the risk of heart attacks, strokes, and other cardiovascular events associated with high cholesterol.\nConvenient Dosage: The fixed-dose combination makes it easier for patients to adhere to their treatment regimen, improving overall effectiveness.\n \n\nHow Does It Work?\n \n\nATOVASTRIN EZ 20/10 works through a dual mechanism to reduce cholesterol levels:\n\nAtorvastatin Calcium inhibits HMG-CoA reductase, an enzyme in the liver responsible for producing cholesterol. By blocking this enzyme, Atorvastatin reduces the production of cholesterol, particularly LDL cholesterol, and increases the liver's ability to remove LDL cholesterol from the blood.\n\nEzetimibe works by inhibiting the absorption of cholesterol in the small intestine. This reduces the amount of cholesterol delivered to the liver, prompting the liver to take up more cholesterol from the blood, thereby lowering overall cholesterol levels.\n\nTogether, these actions significantly reduce the levels of LDL cholesterol and triglycerides while slightly increasing HDL cholesterol, providing a comprehensive approach to managing cholesterol.\n\n \n\nDirections for Use:\n \n\nDosage: Take ATOVASTRIN EZ 20/10 exactly as prescribed by your healthcare provider. The typical dosage is one tablet daily, with or without food.\nTiming: It's recommended to take the medication at the same time each day to maintain consistent levels in your bloodstream.\nSwallowing: Swallow the tablet whole with water. Do not crush, chew, or break the tablet, as this may affect the drug's effectiveness.\nAdherence: Continue taking ATOVASTRIN EZ 20/10 even if you feel well. High cholesterol usually does not have symptoms, so it’s essential to maintain your medication schedule to manage cholesterol effectively.\n \n\nSide Effects:\n \n\nWhile ATOVASTRIN EZ 20/10 is generally well-tolerated, some individuals may experience side effects. Common side effects include:\n\nMuscle Pain or Weakness: Statins like Atorvastatin may cause muscle-related issues. If you experience unexplained muscle pain, tenderness, or weakness, contact your healthcare provider.\nDigestive Issues: Some users may experience stomach pain, diarrhea, or indigestion. These symptoms are usually mild and temporary.\nHeadache: Headaches are a possible side effect and can be managed with over-the-counter pain relievers if necessary.\nElevated Liver Enzymes: Routine monitoring of liver function may be necessary, as ATOVASTRIN EZ 20/10 can cause an increase in liver enzymes.\n For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 185.0, "discountamount": 56.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "same time", "one tablet", "Ezetimibe IP", "Key Benefits", "heart health", "stomach pain", "heart attacks", "ATOVASTRIN EZ", "liver function", "typical dosage", "Dual Mechanism", "HDL cholesterol", "LDL cholesterol", "small intestine", "high cholesterol", "Digestive Issues", "Convenient Dosage", "HMG-CoA reductase", "treatment regimen", "balanced approach", "consistent levels", "Routine monitoring", "thorough reduction", "medication schedule", "harmful cholesterol", "healthcare provider", "Common side effects", "Atorvastatin Calcium", "Atrovastatin Calcium", "possible side effect", "muscle-related issues", "overall effectiveness", "cholesterol production", "fixed-dose combination", "comprehensive approach", "Elevated Liver Enzymes", "counter pain relievers", "cardiovascular diseases", "unexplained muscle pain", "Cardiovascular Protection", "overall cholesterol levels", "Managing cholesterol levels", "other cardiovascular events", "powerful combination medication", "Comprehensive Cholesterol Control", "two potent cholesterol-lowering agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1949, "imageuri": "https://productimages.withfloats.com/actual/66d6d7eaca1fef302456f6b0.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d6d7eaca1fef302456f6b0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T09:33:18.63Z", "updatedon": "2024-09-03T09:33:18.63Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atrovastatin-calcium-20mg-ezetimibe-ip-10mg-/1949", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATOVASTRIN EZ 20/10 ", "category": "CARDIOLOGYRANGE", "tags": [ "Atrovastatin Calcium (20mg), Ezetimibe IP (10mg) U" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e7ff07e47881008f6860e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIMETAZ CR 80 ", "description": "TRIMETAZ CR 80 \nTrimetazidine (80mg)\nIntroduction\nTRIMETAZ CR 80 is a medication containing Trimetazidine hydrochloride, formulated to treat angina pectoris and certain other cardiovascular conditions. It is known for its metabolic effects on the heart muscle, improving myocardial efficiency and reducing symptoms associated with ischemic heart disease.\n\nComposition\n\nTrimetazidine (80mg): The active ingredient, Trimetazidine, acts as a cellular metabolic agent that enhances myocardial glucose utilization and improves energy production in the heart muscle.\nMechanism of Action\nTrimetazidine exerts its therapeutic effects through several mechanisms:\n\nMetabolic Regulation: Shifts myocardial energy substrate utilization from fatty acids toward glucose oxidation, which is more efficient and requires less oxygen.\nAnti-ischemic Effect: Protects the heart against ischemic damage by preserving cellular energy metabolism and reducing oxidative stress.\nImprovement in Symptomatology: Reduces angina symptoms such as chest pain, shortness of breath, and exercise intolerance by enhancing myocardial function.\nIndications\nTRIMETAZ CR 80 is indicated for:\n\nChronic Stable Angina Pectoris: Used as adjunctive therapy in patients who are inadequately controlled with other anti-anginal medications.\nIschemic Heart Disease: Helps improve myocardial function and reduce symptoms associated with coronary artery disease.\nDosage and Administration\n\nThe usual dosage of TRIMETAZ CR 80 is one tablet (80mg) taken orally twice daily, preferably with meals.\nThe extended-release formulation ensures sustained therapeutic levels of Trimetazidine throughout the day.\nDosage adjustments may be necessary based on individual patient response and tolerance.\nSide Effects\nCommon side effects may include:\n\nHeadache\nDizziness\nNausea\nGastrointestinal disturbances (such as abdominal pain or diarrhea)\nSevere side effects are rare but may include:\n\nAllergic reactions (rash, itching, swelling)\nExtrapyramidal symptoms (involuntary movements)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with severe renal impairment or hepatic dysfunction, as Trimetazidine metabolism may be altered.\nMonitor patients for signs of extrapyramidal symptoms, especially in patients with Parkinson's disease or other movement disorders.\nAvoid abrupt discontinuation of Trimetazidine, as it may worsen angina symptoms.\nDrug Interactions\n\nTrimetazidine may interact with other medications that affect myocardial metabolism or cardiac function, including beta-blockers and calcium channel blockers. Close monitoring is recommended when used concomitantly.\nConclusion\nTRIMETAZ CR 80 is a valuable therapeutic option for managing chronic stable angina pectoris and ischemic heart disease by improving myocardial efficiency and reducing symptoms associated with cardiac ischemia. Its mechanism of action, focusing on metabolic modulation and anti-ischemic effects, makes it an effective adjunctive therapy in patients with inadequate symptom control on standard anti-anginal medications. Proper dosage, administration, and monitoring for side effects are essential to ensure safe and effective use of TRIMETAZ CR 80 in cardiovascular patients. Consultation with a healthcare provider is recommended for personalized treatment plans and management of cardiac conditions with TRIMETAZ CR 80.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 435.0, "discountamount": 130.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one tablet", "chest pain", "less oxygen", "fatty acids", "TRIMETAZ CR", "usual dosage", "heart muscle", "Proper dosage", "effective use", "abdominal pain", "angina symptoms", "ischemic damage", "Close monitoring", "cardiac ischemia", "oxidative stress", "cardiac function", "Drug Interactions", "active ingredient", "glucose oxidation", "metabolic effects", "energy production", "other medications", "Dosage adjustments", "Allergic reactions", "adjunctive therapy", "several mechanisms", "cardiac conditions", "healthcare provider", "Hepatic dysfunction", "myocardial function", "therapeutic effects", "Severe side effects", "Common side effects", "metabolic modulation", "Metabolic Regulation", "liver function tests", "involuntary movements", "anti-ischemic effects", "myocardial efficiency", "myocardial metabolism", "abrupt discontinuation", "ischemic heart disease", "Extrapyramidal symptoms", "cardiovascular patients", "coronary artery disease", "severe renal impairment", "Trimetazidine metabolism", "cellular metabolic agent", "other movement disorders", "calcium channel blockers", "cellular energy metabolism", "inadequate symptom control", "Trimetazidine hydrochloride", "valuable therapeutic option", "individual patient response", "extended-release formulation", "sustained therapeutic levels", "personalized treatment plans", "Gastrointestinal disturbances", "other anti-anginal medications", "myocardial glucose utilization", "Chronic Stable Angina Pectoris", "other cardiovascular conditions", "standard anti-anginal medications", "myocardial energy substrate utilization" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1938, "imageuri": "https://productimages.withfloats.com/actual/668e7ff3f07c99c3af8e8504.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7ff3f07c99c3af8e8504.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:34:56.538Z", "updatedon": "2024-07-10T12:34:56.538Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trimetaz-cr-80-/1938", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIMETAZ CR 80 ", "category": "CARDIOLOGYRANGE", "tags": [ "Trimetazidine 80mg price", "Trimetazidine 35 mg uses", "Trimetazidine 80 mg brand name", "When to stop taking trimetazidine", "Trimetazidine hydrochloride extended release CAPSU", "Trimetazidine mechanism of action", "Trimetazidine 35 mg brand name", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e72553345171da8e569d1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 445.0, "discountamount": 133.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "Hair loss", "INR levels", "high levels", "Weight gain", "motor skills", "correct dose", "initial dose", "Liver damage", "Proper dosage", "effective use", "divided doses", "various types", "valproate ion", "valproic acid", "increased risk", "medical advice", "Concurrent use", "dosing syringe", "manic episodes", "close monitoring", "sodium valproate", "bipolar disorder", "Divalproex Sodium", "active ingredient", "Drug Interactions", "neuronal activity", "dosage adjustments", "Bleeding Disorders", "Regular monitoring", "migraine headaches", "low platelet count", "healthcare provider", "electrical activity", "Common side effects", "effective medication", "anticoagulant effect", "Migraine Prophylaxis", "various neurological", "liver function tests", "1:1 molar relationship", "psychiatric conditions", "potential side effects", "healthcare professional", "gamma-aminobutyric acid", "congenital malformations", "complex absence seizures", "complex partial seizures", "More severe side effects", "other antiepileptic drugs", "optimal clinical response", "administration instructions", "inhibitory neurotransmitter", "mood-stabilizing properties", "mood-stabilizing medication", "DIOWELPREX 250 ORAL SOLUTION", "stable coordination compound", "Gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1933, "imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:36:53.173Z", "updatedon": "2024-07-10T11:36:53.173Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-250-oral-solution-/1933", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX 250 ORAL SOLUTION ", "category": "NEUROLOGY RANGE", "tags": [ "Divalproex 250 mg", "Divalproex side effects", "Divalproex prolonged release tablets", "Divalproex extended release tablets IP 250 mg", "Divalproex prolonged release tablets uses", "Divalproex 250 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6fa253fc1c22985081c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 120 ", "description": "SLIM BOOST CTSTAT 120 \nCetilistat (120mg)\nIntroduction\nSLIM BOOST CTSTAT 120 is an advanced weight management medication containing Cetilistat (120mg), a potent oral lipase inhibitor aimed at aiding weight reduction in individuals struggling with obesity. By preventing the digestion and absorption of dietary fats, Cetilistat helps decrease caloric intake, facilitating weight loss when combined with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (120mg): A lipase inhibitor that specifically targets and inhibits gastrointestinal lipases, crucial enzymes for the digestion of fats.\nMechanism of Action\nCetilistat works by inhibiting the action of pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted in the feces, leading to reduced calorie absorption and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 120 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 120mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and alongside a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Following dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 120, with its active ingredient Cetilistat, provides an effective solution for managing obesity and supporting weight loss efforts. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Adhering to dietary recommendations and monitoring for any adverse effects will help achieve the best outcomes with SLIM BOOST CTSTAT 120.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "dietary fats", "risk factors", "best outcomes", "fecal urgency", "oily spotting", "fat absorption", "obese patients", "typical dosage", "Abdominal pain", "caloric intake", "adequate intake", "Concomitant use", "crucial enzymes", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "dietary guidelines", "fecal incontinence", "Obesity Management", "effective solution", "cyclosporine levels", "Overweight Patients", "weight loss efforts", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "potential side effects", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "reduced calorie absorption", "absorbable free fatty acids", "potent oral lipase inhibitor", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome", "advanced weight management medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1932, "imageuri": "https://productimages.withfloats.com/actual/68316fd9ab217a50d26b6b09.png", "tileimageuri": "https://productimages.withfloats.com/tile/68316fd9ab217a50d26b6b09.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:25:22.65Z", "updatedon": "2025-05-24T07:05:59.696Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-120-/1932", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cetilistat (120mg)", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat dosage", "Cetilistat side effects", "Cetilistat 120 mg side effects", "Cetilistat 120 mg brands in india", "Cetilistat 120 mg Uses in Hindi", "Cetilistat Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6cdd5c559a0c24bb221a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 60 ", "description": "SLIM BOOST CTSTAT 60 \nCetilistat (60mg)\nIntroduction\nSLIM BOOST CTSTAT 60 is a weight management medication containing Cetilistat (60mg), an oral lipase inhibitor designed to assist in weight reduction in individuals with obesity. By inhibiting the digestion and absorption of dietary fats, Cetilistat helps reduce caloric intake, promoting weight loss when used in conjunction with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (60mg): A novel lipase inhibitor that targets gastrointestinal lipases, crucial enzymes for fat digestion.\nMechanism of Action\nCetilistat works by inhibiting pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted, reducing the overall caloric intake and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 60 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 60mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and in conjunction with a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Adherence to dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 60, with its active ingredient Cetilistat, offers an effective solution for weight management in obese and overweight individuals. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Always adhere to dietary recommendations and monitor for any adverse effects to achieve the best outcomes with SLIM BOOST CTSTAT 60.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "risk factors", "dietary fats", "fat digestion", "best outcomes", "fecal urgency", "oily spotting", "obese patients", "fat absorption", "typical dosage", "Abdominal pain", "Concomitant use", "crucial enzymes", "adequate intake", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "Obesity Management", "dietary guidelines", "fecal incontinence", "effective solution", "cyclosporine levels", "Overweight Patients", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "oral lipase inhibitor", "overweight individuals", "overall caloric intake", "potential side effects", "novel lipase inhibitor", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "absorbable free fatty acids", "weight management medication", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1931, "imageuri": "https://productimages.withfloats.com/actual/668e6cdfa916e42e88302495.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e6cdfa916e42e88302495.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:13:33.226Z", "updatedon": "2024-07-10T11:13:33.226Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-60-/1931", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SLIM BOOST CTSTAT 60 ", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat 120 mg Uses in Hindi", "", "Cetilistat dosage", "Cetilistat Tablets", "Cetilistat Brand name", "Cetilistat side effects", "Cetilistat 120 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }